[TVTX] YoY Quarter Result on 31-Dec-2016 [#Q4]

Stock
[TVTX] Travere Therapeutics, Inc.
Announcement Date
01-Mar-2017
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- 76.82%
YoY- -248.44%
Quarter Report
TVTX's Result
TVTX's Financial Summary
View:
Show?
Quarter Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 46,687 43,771 42,177 37,326 30,447 14,085 200 148.03%
PBT -30,227 -7,455 -11,038 -12,288 -12,994 -29,239 -13,058 15.00%
Tax 32 -10,797 6,580 -3,685 -10,525 36,485 11,396 -62.42%
NP -30,259 -7,455 -17,618 -8,603 -2,469 -29,239 -13,134 14.91%
Tax Rate - - - - - - - -
Total Cost 76,946 51,226 59,795 45,929 32,916 43,324 13,334 33.91%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin -64.81 -17.03 -41.77 -23.05 -8.11 -207.59 -6,567.14 -53.66%
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS -0.70 -0.18 -0.45 -0.23 -0.07 -1.08 -0.56 3.78%
EPS Diluted -0.69 -0.18 -0.44 -0.22 -0.07 -0.96 -0.56 3.53%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.